2024-07-15 12:34:50
World-renowned Spanish oncology researcher Mariano Barbacid has decided leave part of your inheritance for cancer research. Although Barbacid says he is “healthy and eager to continue working for many years,” he has previously written that part of his legacy is to continue what has been his life’s greatest mission: curing cancer. “I know that I will have many heirs who will be grateful because the Cris Foundation against cancer will continue to fund research for many years,” he said.
The director also of the Experimental Oncology Group of the National Cancer Research Center -CNIO- remembers that “without research we will not be able to defeat cancer.”
Barbacid leads the CRIS Pancreas Project, an ambitious research that works to develop an effective treatment against pancreatic cancer, a type of tumor with a 95% mortality rate that costs the lives of 7,000 people a year in Spain.
“Cancer is not just one disease, but hundreds of them and some like pancreatic cancer with a very complicated prognosis today. If we invest the necessary resources, my daughters will be able to see the end of it. For them and for all the people who suffered from you, suffered from you and will suffer from you, I want to dedicate part of my wealth to the only thing that can really put an end to it: research.
Cancer is a public health problem, which will affect 1 in 2 men and 1 in 3 women in their lifetime. Also, since last June, tumors have been the main cause of death in Spain.
The most diagnosed tumors in Spain, according to data from the Spanish Society of Medical Oncology -SEOM-, in 2023 are: colon and rectum (42,721 new cases), breast (35,001), lung ( 31,282), saliva (29,002) and bladder fluid (21,694).
The CRIS Foundation against cancer raises funds from civil society to allocate them to research in Public Health, with the aim that all patients have the opportunity to access the latest and appropriate treatments for their type of cancer. “We share the money we receive from legacies and rights to our project; the end of cancer. In fact, if you want, you can specify which project you want to allocate to. We will make sure that his wish has come true,” explains Marta Cardona, general director of the CRIS Foundation against cancer.
This year they will share money received through inheritance and propertys research support pancreatic cancer and inside child cancer. The materials will contribute to the research project led by Dr. Antonio Pérez at the CRIS Unit of Advanced Therapies of the University Hospital of La Paz and a very hopeful line of research: the CRIS Project on the origin of pancreatic cancer directed by Dr. . Meritxell Rovira at IDIBELL Biomedical Research Institute of Bellvitge/Universitat de Barcelona.
#grateful #heirs